You are here

  • Home
  • Archive
  • Volume 79, Issue Suppl 1
  • THU0519 OPTIMAL USE OF CONTRAST ENHANCED MRI FOR CLINICAL TRIALS OF INFLAMMATORY DISEASES: RETROSPECTIVE ANALYSIS OF DATA FROM A PHASE IIB STUDY OF BARICITINIB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS

Citation Tools

Article menu
Download PDFPDF
Scientific Abstracts
Poster Presentations
Thursday, 04 June 2020
Diagnostics and imaging procedures
THU0519 OPTIMAL USE OF CONTRAST ENHANCED MRI FOR CLINICAL TRIALS OF INFLAMMATORY DISEASES: RETROSPECTIVE ANALYSIS OF DATA FROM A PHASE IIB STUDY OF BARICITINIB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Boesen M, Hinton M, Gonzalez-Zabaleta J, et al
THU0519 OPTIMAL USE OF CONTRAST ENHANCED MRI FOR CLINICAL TRIALS OF INFLAMMATORY DISEASES: RETROSPECTIVE ANALYSIS OF DATA FROM A PHASE IIB STUDY OF BARICITINIB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS
Annals of the Rheumatic Diseases 2020;79:498-499.